SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-013776
Filing Date
2023-04-27
Accepted
2023-04-27 08:00:25
Documents
6
Period of Report
2023-04-27

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 770290
2 formdef14a_001.jpg GRAPHIC 3868
3 formdef14a_002.jpg GRAPHIC 20477
4 formdef14a_003.jpg GRAPHIC 22130
5 proxy_001.jpg GRAPHIC 311028
6 proxy_002.jpg GRAPHIC 197237
  Complete submission text file 0001493152-23-013776.txt   1535775
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21617 | Film No.: 23851995
SIC: 2834 Pharmaceutical Preparations